Skip to search.
 TSX Down 0.16% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Celgene Corporation (CELG)

-NasdaqGS
144.82 Down 1.82(1.24%) 4:00PM EDT
|After Hours : 145.45 Up 0.63 (0.44%) 6:15PM EDT
Add to Portfolio
Prev Close:146.64
Open:148.09
Bid:145.01 x 300
Ask:145.45 x 200
1y Target Est:193.21
Beta:1.08
Next Earnings Date:24-Apr-14CELG Earnings announcement
Day's Range:144.08 - 148.09
52wk Range:110.53 - 174.66
Volume:3,384,774
Avg Vol (3m):3,916,290
Market Cap:58.80B
P/E (ttm):42.97
EPS (ttm):3.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 1.24%58.80B
JNJUp 0.04%283.51B

Key Statistics

Forward P/E (1 yr):15.12
P/S (ttm):9.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.29
Quarterly EPS Est (Mar-14) :1.65
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback